Loading Events

Innovation After Hours: Showcase & Graduation Event

Thursday, Apr 18, 2024
320 E Vine Dr, Fort Collins, CO 80524

Join Innosphere Ventures and the Colorado BioScience Association (CBSA)  on Thursday, April 18th at Innosphere HQ as we showcase the startup companies graduating from the first cohort of our “Colorado Life Sciences Incubation Program.” Founders who’ve participated in the 12 month program that are commercializing technologies, devices, and life-saving breakthroughs will present their startups.

Attendees will hear overviews from the graduating companies who are all commercializing life science-based innovations, technologies, products, and biotechnology-related breakthroughs that have global impact, as well as hear from leaders in our ecosystem who are dedicated to advancing our region’s life science technologies

This networking event is an opportunity to learn about the latest developments in our region’s life sciences industry and to connect with professionals, industry leaders and members of our community.

We hope you’ll join us at our headquarters in Fort Collins on Thursday, April 18th beginning at 4 pm!

Presenting companies include the graduating startups of:

EnteroTrack LLC.
EnteroTrack is a clinical-stage company with a unique, clinically validated, ready for growth product for non-invasively monitoring Eosinophilic Esophagitis (EoE). The company’s patented sampling technology also allows simple, home-based monitoring and screening for GI cancers, metabolic conditions, and nutritional optimization.

illumifyDx pioneers proactive medical diagnostics, integrating optical spectroscopy, machine learning, and robotics to revolutionize biomarker identification.

Live Fully
Live Fully’s MoblO2 is redefining supplemental oxygen therapy to comfortably manage oxygen saturation levels while reducing the fear and anxiety often associated with portable oxygen use.

At Lonzevity, we discover Body Dysfunctions before it becomes a disease so that you can live longer.

PFRx, Inc.
PFRx is a pioneering solution aimed at addressing the critical gap in pediatric pelvic health.

Prohibix is developing injectable hyaluronic acid products powered by a HYALUTE™ microparticle technology. This platform technology is a breakthrough in controlling the release of hyaluronic acid in the body, and also serves as an ideal delivery vehicle for a wide range of therapeutics from small molecule drugs to delicate biomacromolecules.

TEGSAL is developing an innovative polymeric wound dressing to control bleeding and prevent bacterial infections in wounds and lacerations. We are working to redefine the standard of care with a sophisticated treatment in a practical form, for military casualty care and emergency trauma settings

Learn More